These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3921839)

  • 1. Evidence of aluminum loading in infants receiving intravenous therapy.
    Sedman AB; Klein GL; Merritt RJ; Miller NL; Weber KO; Gill WL; Anand H; Alfrey AC
    N Engl J Med; 1985 May; 312(21):1337-43. PubMed ID: 3921839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions.
    Bishop NJ; Morley R; Day JP; Lucas A
    N Engl J Med; 1997 May; 336(22):1557-61. PubMed ID: 9164811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminium loading in premature infants during intensive care as related to clinical aspects.
    von Stockhausen HB; Schrod L; Brätter P; Rösick U
    J Trace Elem Electrolytes Health Dis; 1990 Dec; 4(4):209-13. PubMed ID: 2136283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential serum aluminum and urine aluminum: creatinine ratio and tissue aluminum loading in infants with fractures/rickets.
    Koo WW; Krug-Wispe SK; Succop P; Bendon R; Kaplan LA
    Pediatrics; 1992 May; 89(5 Pt 1):877-81. PubMed ID: 1579398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of preterm infants to aluminum in parenteral nutrition.
    Koo WW; Kaplan LA; Krug-Wispe SK; Succop P; Bendon R
    JPEN J Parenter Enteral Nutr; 1989; 13(5):516-9. PubMed ID: 2514293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum exposure from parenteral nutrition in preterm infants: bone health at 15-year follow-up.
    Fewtrell MS; Bishop NJ; Edmonds CJ; Isaacs EB; Lucas A
    Pediatrics; 2009 Nov; 124(5):1372-9. PubMed ID: 19858156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis.
    Andreoli SP; Bergstein JM; Sherrard DJ
    N Engl J Med; 1984 Apr; 310(17):1079-84. PubMed ID: 6708989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum.
    Tsou VM; Young RM; Hart MH; Vanderhoof JA
    Pediatrics; 1991 Feb; 87(2):148-51. PubMed ID: 1987526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to aluminum in parenteral nutrition during infancy.
    Koo WW; Kaplan LA; Bendon R; Succop P; Tsang RC; Horn J; Steichen JJ
    J Pediatr; 1986 Nov; 109(5):877-83. PubMed ID: 3095522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial plasma and urinary aluminum levels and tissue loading in preterm twins.
    Bozynski ME; Sedman AB; Naglie RA; Wright EJ
    JPEN J Parenter Enteral Nutr; 1989; 13(4):428-31. PubMed ID: 2506381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized parenteral nutrition in preterm infants: early impact on fluid and electrolyte balance.
    Iacobelli S; Bonsante F; Vintéjoux A; Gouyon JB
    Neonatology; 2010 Jun; 98(1):84-90. PubMed ID: 20090377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum content in intravenous solutions for administration to neonates: role of product preparation and administration methods.
    de Oliveira SR; Bohrer D; Garcia SC; do Nascimento PC; Noremberg S
    JPEN J Parenter Enteral Nutr; 2010; 34(3):322-8. PubMed ID: 20467015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential aluminum exposure from parenteral nutrition in patients with acute kidney injury.
    Brown RO; Morgan LM; Bhattacharya SK; Johnson PL; Minard G; Dickerson RN
    Ann Pharmacother; 2008 Oct; 42(10):1410-5. PubMed ID: 18728106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum loading in preterm neonates revisited.
    Bohrer D; Oliveira SM; Garcia SC; Nascimento PC; Carvalho LM
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):237-41. PubMed ID: 20479688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition.
    Campfield T; Braden G
    Pediatrics; 1989 Nov; 84(5):860-3. PubMed ID: 2508054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium exposure from parenteral nutrition in preterm infants and later health outcomes during childhood and adolescence.
    Fewtrell MS; Edmonds CJ; Isaacs E; Bishop NJ; Lucas A
    Proc Nutr Soc; 2011 Aug; 70(3):299-304. PubMed ID: 21781356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation.
    Poole RL; Hintz SR; Mackenzie NI; Kerner JA
    JPEN J Parenter Enteral Nutr; 2008; 32(3):242-6. PubMed ID: 18443135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Aluminum Concentrations in Pediatric Patients Receiving Long-Term Parenteral Nutrition.
    Courtney-Martin G; Kosar C; Campbell A; Avitzur Y; Wales PW; Steinberg K; Harrison D; Chambers K
    JPEN J Parenter Enteral Nutr; 2015 Jul; 39(5):578-85. PubMed ID: 24743391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.